- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/15 - DepsipeptidesDerivatives thereof
Patent holdings for IPC class A61K 38/15
Total number of patents in this class: 345
10-year publication summary
|
28
|
32
|
37
|
35
|
33
|
25
|
21
|
27
|
28
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pharma Mar, S.A. | 212 |
26 |
| Celgene Corporation | 1409 |
17 |
| Onkure, Inc. | 30 |
9 |
| Boehringer Ingelheim Animal Health USA Inc. | 418 |
9 |
| St. Jude Children's Research Hospital | 238 |
8 |
| Bayer Animal Health GmbH | 174 |
7 |
| University of Florida Research Foundation, Inc. | 4177 |
7 |
| NovoBiotic Pharmaceuticals, LLC | 23 |
7 |
| Zoetis Services LLC | 1549 |
7 |
| The Trustees of Columbia University in the City of New York | 3631 |
6 |
| Trustees of Boston University | 986 |
6 |
| Viracta Subsidiary, Inc | 17 |
6 |
| Celgene Quanticel Research, Inc. | 154 |
5 |
| Fleurir ABX LLC | 12 |
5 |
| Elanco Animal Health GmbH | 353 |
5 |
| Animol Discovery, Inc. | 18 |
5 |
| Chung-Ang University Industry-Academy Cooperation Foundation | 484 |
4 |
| Desert King International, LLC | 37 |
4 |
| Reapplix ApS | 19 |
4 |
| The Regents of the University of Colorado, a body corporate | 2790 |
4 |
| Other owners | 194 |